| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0003 |